Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply artificial intelligence to the drug development process.
The new round was led by Thrive Capital with participation from Google Ventures. The London-based AI company will receive follow-on capital from existing investor Alphabet.
Isomorphic was spun out of Google DeepMind in 2021.
“This funding will further turbocharge the development of our next-generation…
Article Source
https://news.crunchbase.com/venture/alphabet-backed-isomorphic-google-ai-drug-development/
